He's a vet, not a leading scientist, and how this relates to Dr Joanne Sillince not presenting a paper at the EVA conference is beyond me.
I'm more likely to guess that his importance to IAH has diminished, particularly as most testing will be done at BTBC.
...and was he a director?..and who were the others?..and who really cares..any re-structuring of the board is Rob's concern. not POH shareholders
.
from IAH
· 2h 2 hours ago
We are pleased to have Dr Joanne Sillince rejoin our advisory Board after having a few months off on R&R. Four new USA trial protocols soon.
IAH departures, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(16.7%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.3¢ | 0.2¢ | $2.618K | 1.056M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 88852618 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 60312650 | 22 |
View Market Depth
| Last trade - 11.50am 26/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |